The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases
Abstract
B-cell precursor (BCP) leukemia is the most common form of childhood cancer and the second most common form of acute leukemia in adults. Human BCP leukemia was treated in a severe combined immunodeficient mouse model by targeting of the tyrosine kinase inhibitor Genistein (Gen) to the B cell-specific receptor CD19 with the monoclonal antibody B43. The B43-Gen immunoconjugate bound with high affinity to BCP leukemia cells, selectively inhibited CD19-associated tyrosine kinases, and triggered rapid apoptotic cell death. At less than one-tenth the maximum tolerated dose more than 99.999 percent of human BCP leukemia cells were killed, which led to 100 percent long-term event-free survival from an otherwise invariably fatal leukemia. The B43-Gen immunoconjugate might be useful in eliminating leukemia cells in patients who have failed conventional therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genistein, a specific inhibitor of tyrosine-specific protein kinases.
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., & Fukami, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45614-1 · Cited by 3,724
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Kaufmann, S. H. (1989) · PubMed · Cited by 922
Barry, M. A., Behnke, C. A., & Eastman, A. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90733-2 · Cited by 867
CD19: Lowering the Threshold for Antigen Receptor Stimulation of B Lymphocytes
Carter, R. H., & Fearon, D. T. (1992) · Science · doi:10.1126/science.1373518 · Cited by 674
Adlercreutz, H., Honjo, H., Higashi, A., Fotsis, T., Hämäläinen, E., Hasegawa, T., & Okada, H. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.6.1093 · Cited by 656
Physiologically Based Pharmacokinetic Modeling: Principles and Applications
Gerlowski, L. E., & Jain, R. K. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600721003 · Cited by 576
Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates
Trail, P. A., Willner, D., Lasch, S. J., Henderson, A. J., Hofstead, S., Casazza, A. M., Firestone, R. A., Hellström, I., & Hellström, K. E. (1993) · Science · doi:10.1126/science.8327892 · Cited by 556
Nadler, L. M., Anderson, K. C., Marti, G., Bates, M., Park, E., Daley, J. F., & Schlossman, S. F. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.1.244 · Cited by 486
A program package for simulation and parameter estimation in pharmacokinetic systems
D'argenio, D. Z., & Schumitzky, A. (1979) · Computer Programs in Biomedicine · doi:10.1016/0010-468x(79)90025-4 · Cited by 471
Apoptosis: The Molecular Basis of Cell Death
Tomei, L., & Cope, F. O. (1991) · Medical Entomology and Zoology · Cited by 438
Differentiation-Linked Leukemogenesis in Lymphocytes
Greaves, M. F. (1986) · Science · doi:10.1126/science.3535067 · Cited by 338
Redesigning Nature's Poisons to Create Anti-Tumor Reagents
Vitetta, E. S., Fulton, R. J., May, R. D., Till, M., & Uhr, J. W. (1987) · Science · doi:10.1126/science.3317828 · Cited by 326
CD19 of B Cells as a Surrogate Kinase Insert Region to Bind Phosphatidylinositol 3-Kinase
Tuveson, D. A., Carter, R. H., Soltoff, S. P., & Fearon, D. T. (1993) · Science · doi:10.1126/science.7684160 · Cited by 322
Matsumoto, A. K., Kopicky-Burd, J., Carter, R. H., Tuveson, D. A., Tedder, T. F., & Fearon, D. T. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.1.55 · Cited by 305
Schieven, G., Kirihara, J., Myers, D., Ledbetter, J., & Uckun, F. (1993) · Blood · doi:10.1182/blood.v82.4.1212.1212 · Cited by 264
Self-citationRivera, G. K., Pinkel, D., Simone, J. V., Hancock, M. L., & Crist, W. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310283291801 · Cited by 263
Uckun, F., Jaszcz, W., Ambrus, J., Fauci, A., Gajl-Peczalska, K., Song, C., Wick, M., Myers, D., Waddick, K., & Ledbetter, J. (1988) · Blood · doi:10.1182/blood.v71.1.13.13 · Cited by 227
Self-citationThe Src family of tyrosine protein kinases in hemopoietic signal transduction
Bolen, J. B., Rowley, R. B., Spana, C., & Tsygankov, A. Y. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.15.1281458 · Cited by 215
Self-citationAdlercreutz, H., Fotsis, T., Bannwart, C., Wähälä, K., Brunow, G., & Hase, T. (1991) · Clinica Chimica Acta · doi:10.1016/0009-8981(91)90120-2 · Cited by 198
Tedder, T. F., & Isaacs, C. M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.2.712 · Cited by 192
Uckun, F. M., Tuel-Ahlgren, L., Song, C. W., Waddick, K., Myers, D. E., Kirihara, J., Ledbetter, J. A., & Schieven, G. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9005 · Cited by 191
Self-citationCure of Xenografted Human Tumors by Bispecific Monoclonal Antibodies and Human T Cells
Renner, C., Jung, W. E., Şahin, U., Denfeld, R. W., Pohl, C., Trümper, L. H. P., Hartmann, F., Diehl, V., van Lier, R. A. W., & Pfreundschuh, M. G. (1994) · Science · doi:10.1126/science.8171337 · Cited by 156
Evans, C. A., Owen‐Lynch, P. J., Whetton, A. D., & Dive, C. (1993) · PubMed · Cited by 152
Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogs
Cushman, M., Nagarathnam, D., Burg, D. L., & Geahlen, R. L. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00106a047 · Cited by 151
Uckun, F. M., Schieven, G. L., Dıbırdık, İ., Chandan-Langlie, M., Tuel-ahlgren, L., & Ledbetter, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47397-3 · Cited by 135
Self-citationStamenkovic, I., & Seed, B. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.168.3.1205 · Cited by 123
Immunobiologic differences between normal and leukemic human B-cell precursors.
Uckun, F. M., & Ledbetter, J. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.22.8603 · Cited by 116
Self-citationUckun, F. M., Burkhardt, A. L., Jarvis, L. J., et al. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36907-8 · Cited by 113
Self-citationDivergence of epidermal growth factor and transferrin during receptor-mediated endocytosis
Dickson, R. B., Hanover, J. A., Willingham, M. C., & Pastan, I. H. (1983) · Biochemistry · doi:10.1021/bi00293a033 · Cited by 102
Trevillyan, J. M., Yin, L., Atluru, D., Phillips, C. A., & Bjorndahl, J. M. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3223 · Cited by 101
Tyrosine kinase(s) regulate apoptosis and bcl-2 expression in a growth factor-dependent cell line.
Otani, H., Erdos, M. R., & Leonard, W. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41588-8 · Cited by 94
Uckun, F. M., Dıbırdık, İ., Smith, R. J., Tuel-ahlgren, L., Chandan-Langlie, M., Schieven, G. L., Waddick, K. G., Hanson, M., & Ledbetter, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3589 · Cited by 86
Self-citationTyrosine phosphorylation of CD19 in pre‐B and mature B cells.
Chalupny, N. J., Kanner, S. B., Schieven, G. L., Wee, S. F., Gilliland, L. K., Aruffo, A. A., & Ledbetter, J. A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05930.x · Cited by 81
Expression and Interactions of the Src Family of Tyrosine Protein Kinases in T Lymphocytes
Bolen, J. B., Thompson, P. A., Eiseman, E., & Horak, I. D. (1991) · Advances in cancer research · doi:10.1016/s0065-230x(08)60997-5 · Cited by 78
Self-citationUckun, F. M., Manivel, C. J., Arthur, D. W. Y., Chelstrom, L., Finnegan, D., Tuel-ahlgren, L., Irvin, J., Myers, D. E., & Gunther, R. (1992) · Blood · doi:10.1182/blood.v79.9.2201.2201 · Cited by 78
Self-citationLeukemic B-cell precursors express functional receptors for human interleukin-3
Uckun, F. M., Gesner, T., Song, C., Myers, D., & Mufson, A. (1989) · Blood · doi:10.1182/blood.v73.2.533.533 · Cited by 73
Self-citationLyn tyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells.
Scheuermann, R. H., Racila, E. V., Tucker, T., Yefenof, E., Street, N. E., Vitetta, E. S., Picker, L. J., & Uhr, J. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4048 · Cited by 68
Callard, R. E., Rigley, K. P., Smith, S. H., Thurstan, S. M., & Shields, J. G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.10.2983 · Cited by 54
Pettersson, H., & Kiessling, K. (1984) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/67.3.503 · Cited by 53
Ledbetter, J. A., Rabinovitch, P. S., June, C. H., et al. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.6.1897 · Cited by 50
Cited by
Middleton, E., Kandaswami, C., & Theoharides, T. C. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01472-8 · Cited by 4,882
Phyto-oestrogens and Western Diseases
Adlercreutz, H., & Mazur, W. (1997) · Annals of Medicine · doi:10.3109/07853899709113696 · Cited by 1,279
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., et al. (1996) · Nature · doi:10.1038/379645a0 · Cited by 897
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 778
Multi-targeted therapy of cancer by genistein
Banerjee, S., Li, Y., Wang, Z., & Sarkar, F. H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.052 · Cited by 620
Metadata
- Authors
- Uckun, F. M., Evans, W. E., Forsyth, C. J., Waddick, K. G., Tuel-Ahlgren, L., Chelstrom, L. M., Burkhardt, A., Bolen, J., & Myers, D. E.
- Venue
- Science
- Published
- 1995-02-10
- Volume
- 267
- Issue
- 5199
- Pages
- 886-891
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2112997504
- Cited by
- 271
- References
- 41
- FWCI
- 46.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.